Ketamine & Esketamine at AACAP Annual Meeting 2026
3 sessions on ketamine & esketamine · October 26–31, 2026, Atlanta, GA. Compare ketamine & esketamine at other meetings →
Monday, October 26
16:00–18:00 · Lecture
Treatment Frontiers in Autism and Associated Psychopathology: The Role of Glutamate Modulators
Explores glutamate-modulating treatments for autism and associated psychiatric conditions.
Autism & Neurodevelopmental Disorders · Drug Pipeline & Clinical Trials
Friday, October 30
07:00–08:30 · Session
Master Clinician Paul E. Croarkin, DO, MS: Evidence-Based Interventional Psychiatry in Children and Adolescents
A clinical consultation breakfast reviewing evidence, safety, regulatory and ethical issues for TMS, ECT, electrical stimulation, ketamine/esketamine and emerging psychedelic approaches in youth with treatment-resistant disorders. Uses case-based discussion on patient selection and consent/assent.
Child & Adolescent · Neuromodulation (ECT, TMS) · Treatment-Resistant Depression
Posters (1)
- Ketamine for Depression in Adolescents: Exploring Metabolites as Predictors of Treatment Response in a Randomized Midazolam-Controlled Study — Jacob Lister et al.
Other topics at this meeting
Child & Adolescent 1361Autism & Neurodevelopmental Disorders 272Diverse & Underserved Populations 231Practice, Policy & Workforce 171Psychotherapy 166Education & Training 156Digital Psychiatry & AI 149Measurement-Based Care & Diagnosis 145ADHD 135Neuroscience & Mechanisms 124PTSD & Trauma 114Suicide & Self-Harm 110